Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Subha Shankar, Das"'
Autor:
Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa CB
Publikováno v:
Diagnostics, Vol 13, Iss 13, p 2221 (2023)
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://doaj.org/article/a53148a1b8f04a6fbe601b31facf752c
Autor:
Parul Thakral, Divya Manda, Subha Shankar Das, Pankaj Tandon, Virupakshappa CB, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:8-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243d937bc743dbe204ada5ef02b9b98e
https://doi.org/10.1089/cbr.2022.0029
https://doi.org/10.1089/cbr.2022.0029
Autor:
CB, Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa
Publikováno v:
Diagnostics; Volume 13; Issue 13; Pages: 2221
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::ec47efe47af09625d5d3128abb4792ab
Autor:
Parul Thakral, Subha Shankar Das, Shweta Dhiman, Divya Manda, C.B. Virupakshappa, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486ca4f64a0a33ac14c32ad0a6764ff1
https://doi.org/10.1089/cbr.2022.0080
https://doi.org/10.1089/cbr.2022.0080
Publikováno v:
Clinical Nuclear Medicine. 47:e500-e502
Neoplastic causes account for approximately 10% to 20% cases of PUO (pyrexia of unknown origin). The mechanisms by which malignancies induce fever are not fully understood. The release of pyrogenic cytokines either directly from tumor cells or from m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50308b3358e82d3cecc46791449a45c0
https://doi.org/10.1097/rlu.0000000000004176
https://doi.org/10.1097/rlu.0000000000004176
Autor:
Divya, Manda, Parul, Thakral, Ishita, Sen, Subha Shankar, Das, Virupakshappa, Cb, Dharmender, Malik
Publikováno v:
Clinical Nuclear Medicine.
Differentiating infection and sterile inflammation is the main clinical concern of clinicians as they are closely related to each other. Although 18 F-FDG PET/CT imaging is widely used, its main disadvantage is its lack of specificity to discriminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6655f2d5b10d916ecac551c7d4f8ff66
https://doi.org/10.1097/rlu.0000000000004317
https://doi.org/10.1097/rlu.0000000000004317
Autor:
Parul, Thakral, Divya, Manda, Subha Shankar, Das, Pankaj, Tandon, Virupakshappa, Cb, Dharmender, Malik, Ishita, Sen
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c360f991cb87086a021d45c4dfb324ec
https://pubmed.ncbi.nlm.nih.gov/35763304
https://pubmed.ncbi.nlm.nih.gov/35763304
Autor:
Vinod Raina, Parul Thakral, Vineet Pant, Priya Tiwari, Subha Shankar Das, Ishita Sen, Divya Manda
Publikováno v:
Annals of Nuclear Medicine. 35:794-810
225Ac-PSMA-617 therapy has shown good response in many recent studies. We report our experience of targeted alpha therapy with 225Ac-PSMA-617 in mCRPC patients who have failed therapy with taxanes. Thirty-eight patients with CRPC with progressive dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b51dc9af1cd5839ce2efb1a2a5030b99
https://doi.org/10.1007/s12149-021-01617-4
https://doi.org/10.1007/s12149-021-01617-4
Autor:
Subha Shankar Das, Dharmender Malik, Ishita Sen, Divya Manda, Virupakshappa Cb, Parul Thakral
Publikováno v:
Clinical Nuclear Medicine. 47:e167-e169
Prostatic malignancy is the most common type of nonskin cancer and associated with significant morbidity and mortality. Early androgen deprivation therapy (ADT) is the treatment of choice in metastatic prostate cancer, whereas ADT delays progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d0a79b613333c478d2e8e5ccfbf30ba
https://doi.org/10.1097/rlu.0000000000003890
https://doi.org/10.1097/rlu.0000000000003890
Autor:
Virupakshappa Cb, Parul Thakral, Subha Shankar Das, Dharmender Malik, Ishita Sen, Divya Manda
Publikováno v:
Clinical Nuclear Medicine
Occurrence of invasive fungal infections has gained significant attention during recent times in patients with COVID-19. Patients with severe form of COVID-19, such as those treated in the intensive care unit with prolonged steroid use, are particula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7cac4e803fd15656361d7714bff130
https://doi.org/10.1097/rlu.0000000000003852
https://doi.org/10.1097/rlu.0000000000003852